Martin Daniel C.
Insider CIK 1752827 · DCPH Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 62,971 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 54,667 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 44,600 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 38,900 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | A Award | 2024-06-11 | 2024-06-11 | 20,163 | — | $0 | 75,281 | SEC↗ |
| NA Deciphera Pharmaceuticals, | U Tender | 2024-06-11 | 2024-06-11 | 31,330 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer | 2024-06-11 | 2024-06-11 | 43,951 | — | $0 | 31,330 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2024-02-16 | 2024-02-20 | 2,267 | $15.62 | $35.4K | 55,118 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2024-02-15 | 2024-02-20 | 38,900 | — | $0 | 38,900 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2024-02-15 | 2024-02-20 | 9,725 | — | $0 | 57,385 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2024-01-16 | 2024-01-18 | 1,624 | $14.47 | $23.5K | 47,660 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-12-13 | 2023-12-14 | 1,727 | $15.37 | $26.5K | 49,284 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-12-12 | 2023-12-14 | 5,576 | — | $0 | 51,011 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-11-30 | 2023-12-01 | 17,801 | $12.57 | $223.8K | 45,435 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-10-30 | 2023-10-31 | 1,407 | $12.02 | $16.9K | 62,884 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-10-28 | 2023-10-31 | 5,576 | — | $0 | 64,291 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-06-16 | 2023-06-21 | 1,238 | $14.40 | $17.8K | 58,413 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-02-16 | 2023-02-17 | 1,159 | $15.10 | $17.5K | 58,381 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-02-15 | 2023-02-17 | 44,600 | — | $0 | 44,600 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-02-15 | 2023-02-17 | 11,151 | — | $0 | 59,540 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-01-17 | 2023-01-19 | 1,603 | $21.24 | $34.0K | 48,389 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2022-06-16 | 2022-06-21 | 1,311 | $10.75 | $14.1K | 49,521 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2022-02-16 | 2022-02-18 | 1,146 | $9.05 | $10.4K | 48,668 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 54,667 | — | $0 | 54,667 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2022-01-18 | 2022-01-20 | 13,667 | — | $0 | 49,814 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-12-15 | 2021-12-17 | 62,971 | — | $0 | 62,971 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2021-12-15 | 2021-12-17 | 8,300 | — | $0 | 36,147 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2020-01-22 | 2020-01-24 | 26,999 | — | $0 | 63,001 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-22 | 2020-01-24 | 26,999 | $67.18 | $1.81M | 17,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-01-22 | 2020-01-24 | 26,999 | $36.10 | $974.7K | 43,999 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2019-09-19 | 2019-09-23 | 3,000 | $35.56 | $106.7K | 17,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-01-30 | 2019-02-01 | 52,000 | — | $0 | 52,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2018-09-18 | 2018-09-20 | 20,000 | — | $0 | 20,000 | SEC↗ |